Skip to main content
Premium Trial:

Request an Annual Quote

Delbruck Center Researcher Granted $2.6M for Transposon Research

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Zsuzsanna Izsvák at the Max Delbrück Center for Molecular Medicine has been awarded a five-year, €1.94 million ($2.55 million) grant to study the role of transposons in cancer and other diseases.

Izsvák and her team will use the grant from the European Research Council to investigate transposons under stress conditions triggered by the environment, such as toxins or heavy metals, in order to better understand the relationship between transposon-derived regulatory sequences and human disease, the Delbrück Center said.

The research team will also explore the use of artificially produced transposons for gene therapy.

About half of the human genome consists of transposon-derived sequences, which due to mutations have lost their ability to insert themselves into the host's genome and to spread. While the remnants of transposons had been thought to be "junk DNA," recent studies indicate they can influence gene regulation.

"The human genome is much more complex that previously assumed," Izsvák said in a statement. "In many processes in the body and also in disease, transposons may be the decisive factor. That is why we need to take a closer look at transposons and their influence."

Filed under

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.